rs8059269
Positions:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001330.5(CTF1):c.120C>T(p.Tyr40Tyr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00394 in 1,604,656 control chromosomes in the GnomAD database, including 211 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 109 hom., cov: 31)
Exomes 𝑓: 0.0021 ( 102 hom. )
Consequence
CTF1
NM_001330.5 synonymous
NM_001330.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.292
Genes affected
CTF1 (HGNC:2499): (cardiotrophin 1) The protein encoded by this gene is a secreted cytokine that induces cardiac myocyte hypertrophy in vitro. It has been shown to bind and activate the ILST/gp130 receoptor. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 16-30899509-C-T is Benign according to our data. Variant chr16-30899509-C-T is described in ClinVar as [Benign]. Clinvar id is 44172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr16-30899509-C-T is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-0.292 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0731 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CTF1 | NM_001330.5 | c.120C>T | p.Tyr40Tyr | synonymous_variant | 2/3 | ENST00000279804.3 | NP_001321.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CTF1 | ENST00000279804.3 | c.120C>T | p.Tyr40Tyr | synonymous_variant | 2/3 | 1 | NM_001330.5 | ENSP00000279804.2 | ||
CTF1 | ENST00000395019.3 | c.117C>T | p.Tyr39Tyr | synonymous_variant | 2/3 | 1 | ENSP00000378465.3 |
Frequencies
GnomAD3 genomes AF: 0.0215 AC: 3245AN: 150764Hom.: 110 Cov.: 31
GnomAD3 genomes
AF:
AC:
3245
AN:
150764
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00568 AC: 1415AN: 248914Hom.: 52 AF XY: 0.00410 AC XY: 552AN XY: 134708
GnomAD3 exomes
AF:
AC:
1415
AN:
248914
Hom.:
AF XY:
AC XY:
552
AN XY:
134708
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00212 AC: 3076AN: 1453762Hom.: 102 Cov.: 31 AF XY: 0.00174 AC XY: 1259AN XY: 723270
GnomAD4 exome
AF:
AC:
3076
AN:
1453762
Hom.:
Cov.:
31
AF XY:
AC XY:
1259
AN XY:
723270
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0215 AC: 3245AN: 150894Hom.: 109 Cov.: 31 AF XY: 0.0211 AC XY: 1551AN XY: 73664
GnomAD4 genome
AF:
AC:
3245
AN:
150894
Hom.:
Cov.:
31
AF XY:
AC XY:
1551
AN XY:
73664
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 05, 2021 | - - |
not specified Benign:1
Benign, no assertion criteria provided | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Dec 04, 2008 | - - |
Cardiomyopathy Benign:1
Benign, criteria provided, single submitter | clinical testing | CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario | Jun 14, 2016 | - - |
Dilated Cardiomyopathy, Dominant Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at